Prelude Therapeutics Inc. (PRLD): Price and Financial Metrics

Prelude Therapeutics Inc. (PRLD): $4.00

0.28 (-6.54%)

POWR Rating

Component Grades








Add PRLD to Watchlist
Sign Up

PRLD Price/Volume Stats

Current price $4.00 52-week high $6.14
Prev. close $4.28 52-week low $1.66
Day low $3.99 Volume 40,800
Day high $4.37 Avg. volume 61,517
50-day MA $4.35 Dividend yield N/A
200-day MA $3.59 Market Cap 219.72M

PRLD Stock Price Chart Interactive Chart >

Prelude Therapeutics Inc. (PRLD) Company Bio

Prelude Therapeutics, Inc. operates as a cancer drug discovery company. It focuses on the design and development of small molecule agents for cancer medicines. The company was founded by Gopi Krishna Vaddi in 2016 and is headquartered in Wilmington, DE.

PRLD Latest News Stream

Event/Time News Detail
Loading, please wait...

PRLD Latest Social Stream

Loading social stream, please wait...

View Full PRLD Social Stream

Latest PRLD News From Around the Web

Below are the latest news stories about PRELUDE THERAPEUTICS INC that investors may wish to consider to help them evaluate PRLD as an investment opportunity.

AI Meets Biotech: 3 Top Stocks Transforming Medical Science

The AI revolution is bringing big gains to biotechnology, including drugs, antibodies, and synthetic biology.

John Blankenhorn on InvestorPlace | December 16, 2023

Prelude Therapeutics Announces $25 Million Private Placement

WILMINGTON, Del., Dec. 11, 2023 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Nasdaq: PRLD) (“Prelude” or the “Company”), a clinical-stage precision oncology company, today announced a private placement that the Company estimates will result in gross proceeds of approximately $25 million before deducting estimated offering expenses payable by the Company. Proceeds from the private placement will be used to primarily fund the continued advancement of its SMARCA2 portfolio, for working ca

Yahoo | December 11, 2023

Shell's (SHEL) Prelude LNG Facility to Restart in December

Shell's (SHEL) Prelude LNG facility, nearing the completion of extensive maintenance, is poised for a strategic comeback, aiding the global LNG market.

Yahoo | November 28, 2023

Prelude Therapeutics Insiders Are Down US$149k But Regain Some Losses

Insiders who bought US$263.0k worth of Prelude Therapeutics Incorporated ( NASDAQ:PRLD ) stock in the last year have...

Yahoo | November 5, 2023

Q3 2023 Abcellera Biologics Inc Earnings Call

Q3 2023 Abcellera Biologics Inc Earnings Call

Yahoo | November 3, 2023

Read More 'PRLD' Stories Here

PRLD Price Returns

1-mo 16.28%
3-mo -13.61%
6-mo 16.28%
1-year -27.93%
3-year -88.92%
5-year N/A
YTD -6.32%
2023 -29.30%
2022 -51.49%
2021 -82.60%
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!